Clinical Outcome After Multicenter, Open-Label Phase Ii Trial On Post-Surgery Chemoradiation In Combination With Cetuximab In Squamous Cell Carcinoma Of The Head And Neck With High Risk Of Locoregional Recurrence.
JOURNAL OF CLINICAL ONCOLOGY(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要